Research ArticleBasic Science Investigations
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi and Helmut R. Maecke
Journal of Nuclear Medicine June 2014, 55 (6) 976-982; DOI: https://doi.org/10.2967/jnumed.113.133744
Eleni Gourni
1German Cancer Consortium (DKTK), Heidelberg, Germany
2Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany
3German Cancer Research Center (DKFZ), Heidelberg, Germany
Beatrice Waser
4Department of Pathology, University Hospital Bern, Bern, Switzerland; and
Pascal Clerc
5Institut de la Santé et de la Recherche Médicale, Toulouse, France
Daniel Fourmy
5Institut de la Santé et de la Recherche Médicale, Toulouse, France
Jean Claude Reubi
4Department of Pathology, University Hospital Bern, Bern, Switzerland; and
Helmut R. Maecke
2Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 6
June 1, 2014
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi, Helmut R. Maecke
Journal of Nuclear Medicine Jun 2014, 55 (6) 976-982; DOI: 10.2967/jnumed.113.133744
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
Eleni Gourni, Beatrice Waser, Pascal Clerc, Daniel Fourmy, Jean Claude Reubi, Helmut R. Maecke
Journal of Nuclear Medicine Jun 2014, 55 (6) 976-982; DOI: 10.2967/jnumed.113.133744
Jump to section
Related Articles
Cited By...
- Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography
- Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications
- Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
- Triple-Peptide Receptor Targeting In Vitro Allows Detection of All Tested Gut and Bronchial NETs
- Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors